Show simple item record

Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease.

dc.contributor.authorRay, Kausik K
dc.contributor.authorInzucchi, Silvio E
dc.contributor.authorKosiborod, Mikhail N
dc.contributor.authorCherney, David Z I
dc.contributor.authorDwyer, Jamie P
dc.contributor.authorScirica, Benjamin M
dc.contributor.authorBailey, Clifford J
dc.contributor.authorDíaz, Rafael
dc.contributor.authorUdell, Jacob A
dc.contributor.authorSteg, P Gabriel
dc.contributor.authorLapuerta, Pablo
dc.contributor.authorLopes, Renato D
dc.contributor.authorBhatt, Deepak L
dc.contributor.authorSzarek, Michael
dc.contributor.authorPitt, Bertram
dc.contributor.authorCannon, Christopher P
dc.contributor.authorLeiter, Lawrence A
dc.contributor.authorMcGuire, Darren K
dc.contributor.authorLewis, Julia B
dc.contributor.authorRiddle, Matthew C
dc.date.accessioned2021-03-02T15:37:48Z
dc.date.available2021-03-02T15:37:48Z
dc.identifier.citationBhatt D. L. , Szarek M., Pitt B., Cannon C. P. , Leiter L. A. , McGuire D. K. , Lewis J. B. , Riddle M. C. , Inzucchi S. E. , Kosiborod M. N. , et al., "Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease.", The New England journal of medicine, cilt.384, ss.129-139, 2021
dc.identifier.issn0028-4793
dc.identifier.othervv_1032021
dc.identifier.otherav_6d29b619-2be2-45b3-b5d6-39609cae8e6c
dc.identifier.urihttp://hdl.handle.net/20.500.12627/1565
dc.identifier.urihttps://doi.org/10.1056/nejmoa2030186
dc.language.isoeng
dc.titleSotagliflozin in Patients with Diabetes and Chronic Kidney Disease.
dc.typeMakale
dc.relation.journalThe New England journal of medicine
dc.contributor.departmentİstanbul Üniversitesi , İstanbul Tıp Fak , İst Tıp Fak
dc.identifier.volume384
dc.identifier.startpage129
dc.identifier.endpage139
dc.contributor.firstauthorID2505373


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record